"Harringtonines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tetracyclic spiro-BENZAZEPINES isolated from the seeds of CEPHALOTAXUS. They are esters of the alkaloid cephalotaxine and may be effective as antineoplastic agents.
| Descriptor ID |
D006248
|
| MeSH Number(s) |
D03.132.420 D03.633.100.079.533 D03.633.400.624
|
| Concept/Terms |
Harringtonines- Harringtonines
- Cephalotaxine Alkaloids
- Alkaloids, Cephalotaxine
- Cephalotaxus Alkaloids
- Alkaloids, Cephalotaxus
|
Below are MeSH descriptors whose meaning is more general than "Harringtonines".
Below are MeSH descriptors whose meaning is more specific than "Harringtonines".
This graph shows the total number of publications written about "Harringtonines" by people in this website by year, and whether "Harringtonines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Harringtonines" by people in Profiles.
-
A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804. Cancer Chemother Pharmacol. 2009 Apr; 63(5):859-64.
-
Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples. Int J Oncol. 2006 May; 28(5):1099-103.
-
Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase. Cancer. 2003 Sep 01; 98(5):888-93.